THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS

PRZUNTEK H, WESTARP ME, VOHL ML, GERLACH M, Jutzi P, WEKERLE H (1987)
NEUROPHARMACOLOGY 26(2-3): 255-260.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
NEUROPHARMACOLOGY
Band
26
Ausgabe
2-3
Seite(n)
255-260
ISSN
PUB-ID

Zitieren

PRZUNTEK H, WESTARP ME, VOHL ML, GERLACH M, Jutzi P, WEKERLE H. THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS. NEUROPHARMACOLOGY. 1987;26(2-3):255-260.
PRZUNTEK, H., WESTARP, M. E., VOHL, M. L., GERLACH, M., Jutzi, P., & WEKERLE, H. (1987). THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS. NEUROPHARMACOLOGY, 26(2-3), 255-260. doi:10.1016/0028-3908(87)90216-4
PRZUNTEK, H., WESTARP, M. E., VOHL, M. L., GERLACH, M., Jutzi, P., and WEKERLE, H. (1987). THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS. NEUROPHARMACOLOGY 26, 255-260.
PRZUNTEK, H., et al., 1987. THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS. NEUROPHARMACOLOGY, 26(2-3), p 255-260.
H. PRZUNTEK, et al., “THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS”, NEUROPHARMACOLOGY, vol. 26, 1987, pp. 255-260.
PRZUNTEK, H., WESTARP, M.E., VOHL, M.L., GERLACH, M., Jutzi, P., WEKERLE, H.: THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS. NEUROPHARMACOLOGY. 26, 255-260 (1987).
PRZUNTEK, H, WESTARP, ME, VOHL, ML, GERLACH, M, Jutzi, Peter, and WEKERLE, H. “THE EFFECT OF SILYL SUBSTITUTED METHOTREXATE IN THE TREATMENT OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS MEDIATED BY T-LINE CELLS”. NEUROPHARMACOLOGY 26.2-3 (1987): 255-260.

29 References

Daten bereitgestellt von Europe PubMed Central.

Direct proof of autoreactive T-lymphocytes in experimental allergical encephalomyelitis (EAE).
Beer M, von Specht BU, Permanetter W, Brendel W., Acta Neuropathol Suppl 7(), 1981
PMID: 6164238
Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following in-fusions of high-dose methotrexate
Breithaupt, Cancer Treat. Rep. 9(), 1982
Labile lipophilic derivatives of norepinephrine capable of crossing the blood-brain barrier.
Creveling CR, Daly JW, Tokuyama T, Witkop B., Experientia 25(1), 1969
PMID: 5766567
Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate
Galivan, Molec. Pharmac. 17(), 1980
Synthese und pharmakologische Eigenschaften von silylierten Dopaminen und 4,4-Diphenylpiperidinen
Gerlach, Z. Naturforsch. 38b(), 1983
The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy.
Lankelma J, van der Klein E, Ramaekers F., Cancer Lett. 9(2), 1980
PMID: 7189691
Therapy of allergic encephalomyelitis in rats after onset of paralysis
Levine, 1980
Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment.
Milano G, Thyss A, Renee N, Schneider M, Namer M, Boublil JL, Lalanne CM., Cancer Chemother. Pharmacol. 11(1), 1983
PMID: 6883624
The early phase of T-cell line induced EAE
Meyermann, MPGA. Rep. Res. unit MS 3(), 1985
Lipid solubility and drug penetration of the blood brain barrier
Oldendorf, 1974
Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity.
Pavlik EJ, Kenady DE, van Nagell JR, Keaton K, Hanson MB, Donaldson ES, Griffen WO, Flanigan RC., Cancer Chemother. Pharmacol. 11(1), 1983
PMID: 6883628
Weakening of the blood-brain barrier by alcohol-related stresses in the rat.
Phillips SC, Cragg BG., J. Neurol. Sci. 54(2), 1982
PMID: 7201507
Drug entry into the brain.
Rapoport SI, Ohno K, Pettigrew KD., Brain Res. 172(2), 1979
PMID: 466480
Siliciumhaltige Wirkstoffe—Arzneimittel von morgen?
Reimann, Dt. Apoth. Ztg. 118(), 1978
Enhanced transfer of experimental allergic encephalomyelitis with Lewis rat lymph node cells.
Richert JR, Kies MW, Alvord EC Jr., J. Neuroimmunol. 1(2), 1981
PMID: 6175659
A model for brain métastases
Shapiro, 1980
Sila-Piperidine und silylierte Piperidine mit potentieller Antiparkinsonaktivität—Synthesen, Rezeptorbindungsstudien und Einflüsse auf die chemische Signalübertragung im zentralen Nervensystem
Stasch, Naturwissenschaftliche Dissertation (), 1983
Sila-Pharmaka und ihre Bedeutung für die Therapie neurologischer Erkrankungen
Stasch, 1983
Syntheses and properties of bioactive organo-silicon compounds.
Tacke R, Wannagat U., Top Curr Chem 84(), 1979
PMID: 41340
Biologisch aktive siliziumorganische Verbindungen
Voronkov, 1975
T-Zell-Linen übertragene Experimentall-Allergische Encephalomyelitis-vereinfachtes neuropharmakologisches Modell zur Effektivitäts-messung von Immunsuppressiva
Westarp, 1985
Experimental allergic enceph-alomyelitis transferred by myelin basic protein-specific T-line lymphocytes
Westarp, J. Neurol. 232(), 1985
Tissue-specific synthesis of methotrexate polyglutamates in the rat.
Whitehead VM, Perrault MM, Stelcner S., Cancer Res. 35(11 Pt 1), 1975
PMID: 1182692

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 3495744
PubMed | Europe PMC

Suchen in

Google Scholar